Tag: carto 3
J&J MedTech receives US FDA approval for Varipulse PFA platform in...
Johnson & Johnson (J&J) MedTech has announced the US Food and Drug Administration (FDA) approval of the Varipulse pulsed field ablation (PFA) platform for...
ADVERTORIAL: Pulsed field ablation: A new frontier in the treatment of...
This article was sponsored by Biosense Webster
According to data published by Patrick M McCarthy (Feinberg School of Medicine, Chicago, USA) and colleagues in the...
Sheath designed to reduce radiation exposure and improve ablation procedure efficiency...
The CARTO VIZIGO Bi-directional Guiding Sheath is now available in the United States. This is the first commercially available steerable guiding sheath that can be...
New data demonstrates >90% year 1 success rate for radiofrequency ablation...
Biosense Webster, a Division of Johnson & Johnson Medical NV/SA, and a leader in the diagnosis and treatment of cardiac arrhythmias, recently presented new...
Biosense Webster launches Carto 3 system Carto Visitag module with Ablation...
Biosense Webster has launched of the Carto Visitag module with Ablation Index, a new technology providing visual indication based on the integration of power,...